Journal articleEur J Med Chem2021
Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy.
- Journal
- Eur J Med Chem
- Published
- 30 May 2021
- Citations
- 13
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 5
- Targets, Modulators and Delivery Program P30CA036727↗
- Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers R01CA197999↗
- MUC16 in Pancreatic Cancer Progression and Metastasis R01CA208108↗
- Phosphorylated Form of Activated IKKbeta and Pancreatic Cancer R21CA182820↗
- PROTACs for pancreatic cancer therapy R21CA251151↗